These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8956929)

  • 1. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.
    Kälviäinen R; Aikiä M; Mervaala E; Saukkonen AM; Pitkänen A; Riekkinen PJ
    Epilepsy Res; 1996 Nov; 25(3):291-7. PubMed ID: 8956929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [symbol: see text] Tiagabine: add-on treatment for partial seizures.
    Drug Ther Bull; 2000 Jun; 38(6):47-8. PubMed ID: 10912300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.
    Richens A; Chadwick DW; Duncan JS; Dam M; Gram L; Mikkelsen M; Morrow J; Mengel H; Shu V; McKelvy JF
    Epilepsy Res; 1995 May; 21(1):37-42. PubMed ID: 7641674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
    Walton NY; Gunawan S; Treiman DM
    Epilepsy Res; 1994 Dec; 19(3):237-44. PubMed ID: 7698100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Shu V
    Neurology; 1997 Apr; 48(4):1025-31. PubMed ID: 9109894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
    Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
    Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine add-on for drug-resistant partial epilepsy.
    Pereira J; Marson AG; Hutton JL
    Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
    Loiseau P
    Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine.
    Leach JP; Brodie MJ
    Lancet; 1998 Jan; 351(9097):203-7. PubMed ID: 9449883
    [No Abstract]   [Full Text] [Related]  

  • 18. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Open study with tiagabine in partial epilepsy].
    Arroyo S
    Rev Neurol; 2000 Oct 16-31; 31(8):728-32. PubMed ID: 11082879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.